Clinical Trials
38
Active:2
Completed:31
Trial Phases
3 Phases
Phase 1:31
Phase 2:1
Phase 3:5
Drug Approvals
155
FDA:155
Drug Approvals
- Prev
- 1
- 2
- 3
- 4
- 5
- 16
- Next
Clinical Trials
Distribution across different clinical trial phases (37 trials with phase data)• Click on a phase to view related trials
Phase 1
31 (83.8%)Phase 3
5 (13.5%)Phase 2
1 (2.7%)Safety and Bioequivalence of Pimecrolimus Cream 1% and Elidel R in Treatment of Mild to Moderate Atopic Dermatitis
Phase 3
Completed
- Conditions
- Atopic Dermatitis
- Interventions
- First Posted Date
- 2017-09-29
- Last Posted Date
- 2017-09-29
- Lead Sponsor
- Par Pharmaceutical, Inc.
- Target Recruit Count
- 582
- Registration Number
- NCT03297502
Bioequivalence of Two Ciprofloxacin 0.3%/Dexamethasone 0.1% Sterile Otic Suspensions in Otitis Media in Children With Tympanostomy Tubes
Phase 3
Terminated
- Conditions
- Otitis Media in Patients With Tympanostomy Tubes
- Interventions
- Drug: Placebo Sterile Otic Suspension
- First Posted Date
- 2013-11-26
- Last Posted Date
- 2017-09-26
- Lead Sponsor
- Par Pharmaceutical, Inc.
- Target Recruit Count
- 203
- Registration Number
- NCT01994642
- Locations
- 🇺🇸
Birmingham Pediatrics, Birmingham, Alabama, United States
🇺🇸Agave Clinical Ressearch, Mesa, Arizona, United States
🇺🇸Arizona Center for Clinical Trials, Phoenix, Arizona, United States
A Bioequivalence Study of Two Ciprofloxacin/Dexamethasone Formulations in Patients With Otitis Externa
Phase 3
Terminated
- Conditions
- Otitis Externa
- Interventions
- First Posted Date
- 2013-07-29
- Last Posted Date
- 2016-10-18
- Lead Sponsor
- Par Pharmaceutical, Inc.
- Target Recruit Count
- 455
- Registration Number
- NCT01910155
- Locations
- 🇺🇸
James Donivan Gordon, MD, Tucson, Arizona, United States
🇺🇸Nea Baptist Clinic, Jonesboro, Arkansas, United States
🇺🇸Applied Reserch Center, Little Rock, Arkansas, United States
Bioequivalence Study of Doxycycline Monohydrate Tablets Under Fed Conditions
Phase 1
Completed
- Conditions
- To Determine Bioequivalence Under Fed Conditions
- Interventions
- First Posted Date
- 2011-06-27
- Last Posted Date
- 2017-09-26
- Lead Sponsor
- Par Pharmaceutical, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT01380496
- Locations
- 🇨🇦
Anapharm Inc., Sainte-Foy, Quebec, Canada
Bioavailability Study of Dronabinol Capsules 10 mg Under Fasting Conditions
Phase 1
Completed
- Conditions
- To Determine Bioequivalence Under Fasting Conditions
- Interventions
- First Posted Date
- 2011-06-27
- Last Posted Date
- 2011-06-27
- Lead Sponsor
- Par Pharmaceutical, Inc.
- Target Recruit Count
- 69
- Registration Number
- NCT01380457
- Locations
- 🇺🇸
BASi, Baltimore, Maryland, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 8
- Next
News
No news found